Publications by authors named "Martin Brecher"

Claim this Profile
I
In reply.
Patricia K Duffner, Floyd Daniel Armstrong, Kathleen Helton, Martin L Brecher, Beverly Bell

J Pediatr Hematol Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.
Patricia K Duffner, Floyd Daniel Armstrong, Lu Chen, Kathleen J Helton, Martin L Brecher

J Pediatr Hematol Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Medich giant platelet syndrome: two new cases.
William Gunning, Mukund Dole, Martin Brecher, James G White

Platelets· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study.
Jean-Pierre Lindenmayer, David Brown, Sherry Liu, Martin Brecher, Didier Meulien

Psychopharmacol Bull· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
Andrew J Cutler, Tram Tran-Johnson, Amir Kalali, Mikael Aström, Martin Brecher

Psychopharmacol Bull· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.
David E Kemp, Stephen J Ganocy, Martin Brecher, Berit X Carlson, Suzanne Edwards

J Affect Disord· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term symptomatic remission of schizophrenia with once-daily extended release quetiapine fumarate: post-hoc analysis of data from a randomized withdrawal, placebo-controlled study.
Joseph Peuskens, Jitendra K Trivedi, Martin Brecher, Frank Miller,

Int Clin Psychopharmacol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies.
Didier Meulien, Karin Huizar, Martin Brecher

Hum Psychopharmacol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
Susan L McElroy, Richard H Weisler, William Chang, Bengt Olausson, Björn Paulsson, Martin Brecher

J Clin Psychiatry· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
Allan H Young, Susan L McElroy, Michael Bauer, Nabil Philips, William Chang, Martin Brecher

J Clin Psychiatry· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
Trisha Suppes, Eduard Vieta, Sherry Liu, Martin Brecher, Björn Paulsson

Am J Psychiatry· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.
John W Newcomer, Robert E Ratner, Jan W Eriksson, Robin Emsley, Didier Meulien, Martin Brecher

J Clin Psychiatry· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study.
Andrew J Cutler, Stuart A Montgomery, David Feifel, Arthur Lazarus, Mikael Aström, Martin Brecher

J Clin Psychiatry· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.
Michael Bauer, Herman W Pretorius, Eric L Constant, Willie R Earley, Johan Szamosi, Martin Brecher

J Clin Psychiatry· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release.
Carlos Figueroa, Martin Brecher, Jennifer E Hamer-Maansson, Helen Winter

Prog Neuropsychopharmacol Biol Psychiatry· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder.
Robert Arbuckle, Mark A Frye, Martin Brecher, Björn Paulsson, Kitty Rajagopalan

Psychiatry Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Eduard Vieta, Trisha Suppes, Ivan Eggens, Inger Persson, Björn Paulsson, Martin Brecher

J Affect Disord· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ewing sarcoma of the mandibular condyle: multidisciplinary management optimizes outcome.
Lynn W Solomon, Jennifer L Frustino, Thom R Loree, Martin L Brecher, Ronald A Alberico

Head Neck· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia.
Hans-Jürgen Möller, Sunny Johnson, Temenuzhka Mateva, Martin Brecher, Ola Svensson

Int Clin Psychopharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients.
Joseph Peuskens, Jitendra Trivedi, Sergiy Malyarov, Martin Brecher, Ola Svensson

Psychiatry (Edgmont)· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Peter F Buckley, Björn Paulsson, Martin Brecher

J Affect Disord· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
Caleb M Adler, David E Fleck, Martin Brecher, Stephen M Strakowski

J Affect Disord· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.
Aleksandra Kowalczyk, Andrzej Wierzbicki, Margaret Gil, Barbara Bambach, Yutaro Kaneko, Martin Brecher

Cancer Immunol Immunother· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.
René S Kahn, S Charles Schulz, Veselin D Palazov, Efren B Reyes, Martin Brecher

J Clin Psychiatry· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia.
Martin Brecher, Ronald W Leong, Göran Stening, Lisa Osterling-Koskinen, A Martin Jones

J Clin Psychiatry· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis